Results 191 to 200 of about 6,425,570 (316)

Evaluation and Public Health

American Journal of Public Health, 2004
openaire   +3 more sources

Clinical Implication of Maumgyeol Basic Service-the 2 Channel Electroencephalography and a Photoplethysmogram-based Mental Health Evaluation Software. [PDF]

Clin Psychopharmacol Neurosci, 2023
Lee SH, Hwang HH, Kim S, Hwang J, Park J, Park S.   +5 more
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Avaliação do programa de prevenção e promoção da saúde de fenilcetonúricos

Revista de Saúde Pública
OBJETIVO: Avaliar os resultados de ações preventivas e de promoção à saúde institucionalizadas para crianças fenilcetonúricas. MÉTODOS: Foram avaliados os resultados alcançados pelo Programa de Triagem Neonatal, do Estado do Paraná, entre os ...
Salete do Rocio Cavassin Brandalize, Dina Czeresnia   +1 more
doaj  

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Examining the Severity and Consequences of Patients Admitted With Acute Chest Pain via the Acute Physiology and Chronic Health Evaluation II Score and the Relevance of Adding High-Sensitivity Troponin Testing. [PDF]

Cureus
Farag Y, Breika NM, Omar A, Owis ME, Abdelrazek M, Soliman M, Embabi A, Nour R, Essam Muhamad Eldeeb M, Ebrahim MF, Muhammad AAA, Ataalla AG, Elzohary A, Saad Ramadan MT, Tawdros AEH, Elsayed AMM, Salem NAMA.   +16 more
europepmc   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Effect of probiotic <i>Limosilactobacillus reuteri</i> on a serum sex-hormone- and metabolic-syndrome-related health evaluation: a single-arm open-label pilot study. [PDF]

Biosci Microbiota Food Health
Noda M, Danshiitsoodol N, Kanno K, Yonezawa S, Ishida R, Sugiyama M.   +5 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source